Mengyang Di

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Psychometric Properties

Hodgkin Lymphoma

Top Venues

Leukemia & lymphoma

JNCI cancer spectrum

JCO oncology practice

Journal of the American Geriatrics Society

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyang Di, Christopher T Su, Andrew J Cowan, Ajay K Gopal, Rahul Banerjee
Mitigating time toxicity in lymphoma and multiple myeloma. Leukemia & lymphoma (2024)
Caroline Raymundo, David Cella, Lynne Wagner, Daniel S Hippe, Mengyang Di, Joan Guitart, Steven T Rosen, Christiane Querfeld, Michi M Shinohara
Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL). The British journal of dermatology (2024)
Mengyang Di, Kunal C Potnis, Jessica B Long, Iris Isufi, Francine Foss, Stuart Seropian, Cary P Gross, Scott F Huntington
Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas. JNCI cancer spectrum 8 (4) (2024)
Mengyang Di, Kunal C Potnis, Jessica B Long, Iris Isufi, Francine Foss, Stuart Seropian, Cary P Gross, Scott F Huntington
Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas. JNCI cancer spectrum 8 (4) (2024)
Mengyang Di, Tamra Keeney, Emmanuelle Belanger, Scott F Huntington, Adam J Olszewski, Orestis A Panagiotou
Functional status and therapy for older adults with diffuse large B-cell lymphoma in nursing homes: A population-based study. Journal of the American Geriatrics Society (2023)
Mengyang Di, Can Cui, Shalin K Kothari, Amer M Zeidan, Nikolai A Podoltsev, Natalia Neparidze, Rory Michael Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis. Blood advances 6 (11) (2022)
Connor Graham, Catherine Metayer, Libby M Morimoto, Joseph L Wiemels, Arfan Siddique, Mengyang Di, Rozalyn L Rodwin, Nina S Kadan-Lottick, Xiaomei Ma, Rong Wang
Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case-Control Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (9) (2022)
Mengyang Di, Tamra Keeney, Emmanuelle Belanger, Orestis A Panagiotou, Adam J Olszewski
Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study. JCO oncology practice (2021)
Mengyang Di, Orestis A Panagiotou, John L Reagan, Rabin Niroula, Adam J Olszewski
Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†. Leukemia & lymphoma 61 (14) (2020)
Mengyang Di, Thomas A Ollila, Adam J Olszewski
Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based study. Leukemia 34 (10) (2020)
Mengyang Di, Scott F Huntington, Adam J Olszewski
Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients. The oncologist 26 (2) (2020)
Mengyang Di, Jessica Bian, James N Butera
A new onset of thrombocytopenia and microangiopathic hemolytic anemia in the healthcare setting: A challenge for diagnosis. American journal of hematology 94 (1) (2018)